Nov 1 (Reuters) - Bionomics Ltd (BNO) : BIONOMICS RECEIVES FDA...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Nov 1 (Reuters) - Bionomics Ltd (BNO) :

    • BIONOMICS RECEIVES FDA CLEARANCE OF IND FOR EVALUATION OF BNC210 IN A PHASE 2 SOCIAL ANXIETY DISORDER PREVAIL STUDY
    • BIONOMICS LTD - PREVAIL STUDY REMAINS ON TARGET TO INITIATE BY END OF 2021 AND IS EXPECTED TO READ OUT TOPLINE DATA BY END OF 2022
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.